Home›Stock Screener›Progrex Ventures›Intrinsic Value

Progrex Ventures Intrinsic Value

Progrex Ventures intrinsic value. Progrex Ventures (PROGREXV) median intrinsic value is ₹17.50 from 1 valuation models (range ₹18–₹18), vs current price ₹27.58 — -36.5% downside (Trading Above Calculated Value), margin of safety -57.6%. Analyse PROGREXV FII DII holdings to track promoter, FII and institutional holdings.

Market Price (CMP)
₹27.58
Primary Intrinsic Value
₹17.50
Market Cap
₹11.0 Cr
-36.5% Downside
Median Value
₹17.50
Value Range
₹18 - ₹18
Assessment
Trading Above Calculated Value
Safety Margin
-57.6%

PROGREXV Valuation Methods Summary — DCF, Graham Number & P/E

Progrex Ventures intrinsic value across 1 models vs current price ₹27.58 — upside/downside and value range per method. For current market price and key ratios, visit PROGREXV share price screener.

Method Type Intrinsic Value Range Upside/Downside Details
Book Value Method asset ₹17.50 ₹15.75 - ₹19.25 -36.5% Book Value/Share: ₹17.50, P/B: 1.0x
Method Types: Earnings Asset DCF Growth Dividend Conservative

PROGREXV Intrinsic Value vs Market Price — All Valuation Models

Progrex Ventures fair value range ₹18–₹18 vs current market price ₹27.58 across 1 valuation models. Browse PROGREXV cash flow statement for revenue, profit, balance sheet and cash flow data.

PROGREXV Intrinsic Value Analysis — Undervalued or Overvalued?

Progrex Ventures median intrinsic value ₹17.50, current price ₹27.58 — Trading Above Calculated Value by 36.5%, margin of safety -57.6%.

What is the intrinsic value of PROGREXV?

Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Progrex Ventures (PROGREXV) is ₹17.50 (median value). With the current market price of ₹27.58, this represents a -36.5% variance from our estimated fair value.

The valuation range spans from ₹17.50 to ₹17.50, indicating ₹17.50 - ₹17.50.

Is PROGREXV undervalued or overvalued?

Based on our multi-method analysis, Progrex Ventures (PROGREXV) appears to be trading above calculated value by approximately 36.5%.

PROGREXV Financial Health — Key Ratios vs Industry Benchmarks

Progrex Ventures financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 8.00 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Debt to Equity Ratio 1.29 Industry Standard: <0.5 Above 1.0 Indicates financial leverage level

PROGREXV Cash Flow Quality — Operating & Free Cash Flow

Progrex Ventures operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2025 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2024 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2023 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2022 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10
March 2021 ₹0 Cr ₹0 Cr Negative Cash Flow 3/10